Peripheral blood CD4(pos)CD25(pos)FoxP3(pos) cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig

BACKGROUND: Prognostic biomarkers of treatment response to distinct biologic disease-modifying anti-rheumatic drugs (b-DMARDs) are still lacking within the management of rheumatoid arthritis (RA). METHODS: Thirty-four b-DMARDs naive RA patients, divided by disease duration into early (cohort 1) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Elisa, Gremese, Tolusso, Barbara, Petricca, Luca, Di Mario, Clara, Gigante, Maria Rita, Ferraccioli, Gianfranco, Alivernini, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199213/
https://www.ncbi.nlm.nih.gov/pubmed/35706043
http://dx.doi.org/10.1186/s13075-022-02827-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199213/
https://www.ncbi.nlm.nih.gov/pubmed/35706043
http://dx.doi.org/10.1186/s13075-022-02827-5

Ejemplares similares